CALR and hepatocellular carcinoma: In this study we found that targeting STAT3 could induce ICD of HCC cells, which manifested as translocation of “eat me” molecules such as calreticulin to the cell surface, while exposure of the “don't eat me” molecule CD47 significantly decreased.